abstract |
Provided is a T cell receptor (TCR) capable of specifically binding oligopeptide SLLMWITQC derived from NY-ESO-1 antigens. The antigen oligopeptide SLLMWITQC can form a compound with HLA A0201, and the compound is presented to a cell surface. Also provided are a nucleic acid molecule for coding the TCR and a carrier containing the nucleic acid molecule as well as a cell transducing the TCR. |